The use of oral pioglitazone in the treatment of lichen planopilaris

J Am Acad Dermatol. 2015 Feb;72(2):355-6. doi: 10.1016/j.jaad.2014.10.036.

Authors

Natasha Atanaskova Mesinkovska¹, Alejandra Tellez², Danyelle Dawes³, Melissa Piliang², Wilma Bergfeld²

Affiliations

¹ Dermatology and Plastic Surgery Institute, Cleveland Clinic, Cleveland, Ohio. Electronic address: mesinkn2@ccf.org.
² Dermatology and Plastic Surgery Institute, Cleveland Clinic, Cleveland, Ohio.
³ Department of Dermatology, University Hospitals Case Medical Center, Cleveland, Ohio.

PMID: 25592345
DOI: 10.1016/j.jaad.2014.10.036

No abstract available

Publication types

Letter

MeSH terms

Administration, Oral
Alopecia / etiology
Alopecia / prevention & control*
Disease Progression
Edema / etiology
Female
Follow-Up Studies
Humans
Lichen Planus / complications
Lichen Planus / drug therapy*
Middle Aged
PPAR gamma / agonists*
Pioglitazone
Remission Induction
Retrospective Studies
Thiazolidinediones / administration & dosage*
Thiazolidinediones / adverse effects
Treatment Outcome

Substances

PPAR gamma
Thiazolidinediones
Pioglitazone